Kidney Cancer

Latest News

First patient dosed with TLX250-CDx in Italy for ccRCC
First patient dosed with TLX250-CDx in Italy for ccRCC

March 25th 2024

With the dosing of the first patient in Italy, Telix’s expanded access program for TLX250-CDx in ccRCC now includes 3 active countries, including the Netherlands and the US.

Study progresses of KVA12123 in solid tumors, including renal cell carcinoma
Study progresses of KVA12123 in solid tumors, including renal cell carcinoma

March 15th 2024

Metabolic syndrome increases risk of cancer, including kidney cancer
Metabolic syndrome increases risk of cancer, including kidney cancer

March 13th 2024

Dosing begins in ccRCC cohort of study assessing KO-2806
Dosing begins in ccRCC cohort of study assessing KO-2806

March 6th 2024

Male doctor hand hold silver pen | Image Credit: @ H_Ko - stock.adobe.com
NPX887 being explored in HHLA2+ solid tumors, including RCC

March 1st 2024

Video Interviews

More News

© 2024 MJH Life Sciences

All rights reserved.